Treatment Patterns, Disease Burden, and Outcomes in Patients with Giant Cell Arteritis and Polymyalgia Rheumatica: A Real-World, Electronic Health Record-Based Study of Patients in Clinical Practice

INTRODUCTION: Because of the chronic nature of giant cell arteritis (GCA) and/or polymyalgia rheumatica (PMR), patients may require continued glucocorticoid treatment to achieve treatment targets or prevent disease relapse, resulting in high cumulative doses. This study evaluated patterns of glucoco...

Descripción completa

Detalles Bibliográficos
Autores principales: Craig, Gary, Knapp, Keith, Salim, Bob, Mohan, Shalini V., Michalska, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991019/
https://www.ncbi.nlm.nih.gov/pubmed/33638132
http://dx.doi.org/10.1007/s40744-021-00290-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991019/
https://www.ncbi.nlm.nih.gov/pubmed/33638132
http://dx.doi.org/10.1007/s40744-021-00290-3

Ejemplares similares